Successful use of propranolol for congenital hepatic hemangioma with Kasabach-Merritt phenomenon

Pediatr Int. 2017 May;59(5):634-636. doi: 10.1111/ped.13244. Epub 2017 Apr 12.

Authors

Yuta Kawahara¹, Hitomi Nijima¹, Yume Suzuki¹, Rieko Furukawa², Akira Morimoto¹

Affiliations

¹ Department of Pediatrics, Jichi Medical University School of Medicine, Shimotsuke, Japan.
² Department of Pediatric Medical Imaging, Jichi Medical University School of Medicine, Shimotsuke, Japan.

PMID: 28402071
DOI: 10.1111/ped.13244

No abstract available

Keywords: Kasabach-Merritt phenomenon; congenital hemangioma; corticosteroid; hepatic hemangioma; propranolol.

Publication types

Case Reports

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Humans
Infant, Newborn
Kasabach-Merritt Syndrome / congenital
Kasabach-Merritt Syndrome / diagnosis
Kasabach-Merritt Syndrome / drug therapy*
Liver Neoplasms / congenital
Liver Neoplasms / diagnosis
Liver Neoplasms / drug therapy*
Male
Propranolol / therapeutic use*

Substances

Adrenergic beta-Antagonists
Propranolol